Back to companies
Atea Pharmaceuticals, Inc.
AVIRUSNASDAQPharmaceuticals & HealthcareAtea Pharmaceuticals, Inc.
Revenue
—
FY2025
Operating income
-$180.9mn
FY2025
Employees
—
Founded
—
Source: U.S. Securities and Exchange Commission (SEC) EDGAR Company Facts API